4.8 Article

Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders

期刊

SCIENCE ADVANCES
卷 5, 期 2, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aau9425

关键词

-

资金

  1. INSERM
  2. Universite Pierre et Marie Curie [UPMC-Paris6]
  3. Agence Nationale de la Recherche (ANR EPIFEGRO 2010)
  4. People Programme Marie Curie Actions (MCA) of the European Union [290123]
  5. Societe Francaise d'Endocrinologie et Diabetologie Pediatrique through a Lilly grant
  6. Novo Nordisk Growth Hormone, Growth and Metabolism grant

向作者/读者索取更多资源

Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/ MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 downregulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据